CD8A and neoplasm: Thus, a potent antigen delivery strategy leading to efficient antigen presentation by DCs and activation of specific CD8+ T cell clones represents a promising therapeutic strategy to induce a potent and long lasting PDAC directed immunity finally leading to the elimination or at least control of the tumor burden.